This is amazing news. An Israel company not only believes they have found a cure for cancer, but believe that in a year’s time it will be a complete cure for all cancers. The medicine could only be a few years away from being available to the public!
CBN NEWS – A team of Israeli scientists believes it may have found the cure of all cures to finally end cancer.
“We believe we will offer in a year’s time a complete cure for cancer,” said Dan Aridor, chairman of the board of Accelerated Evolution Biotechnologies Ltd. (AEBi). That’s a bold prediction, and some scientists are urging caution. But here’s how the treatment would work.
“We didn’t want to have another drug like everyone else that would give relief to some cancer patients and then the cancer would come back. We wanted really to cure something like antibiotics,” AEBi CEO Dr. Ilan Morad tells CBN News.
The Israeli scientists studied why previous cancer drugs failed. One reason why cancer drugs fail is because they only attack one specific target in or on one cancer cell at a time. Mutations in the cancer cells make the anti-cancer drugs ineffective.
However, their treatment known as MuTaTo, or multi-target toxin, would use several cancer-targeting peptides on a single cancer cell at once, along with a cancer-destroying toxin.
Dr. Morad says his miracle drug uses an anti-cancer cocktail to ensure “that the treatment will not be affected by mutations; cancer cells can mutate in such a way that targeted receptors are dropped by the cancer.”
“The main thing here is the multiple targeting. So instead of attacking one target at a time we connect together several peptides and we attack several targets at a time. And because of that, the cancer won’t be able – statistically – it won’t be able to escape the therapy and this is what happened with AIDS. And this is what would happen here in cancer,” said Dr. Morad.
Another reason why cancer drugs fail and the disease returns is because the drugs do not destroy cancer stem cells.
“If it does not completely annihilate the cancer, the remaining cells can start to get mutations again, and then the cancer comes back, but this time it is drug resistant,” Morad said.
However, he says MuTaTo is small, flexible, and strong enough to both destroy stem cells and penetrate where other drugs cannot reach.
“This should make the whole molecule non-immunogenic in most cases and would enable repeated administration of the drug,” Morad said.
Morad also said MuTaTo will decrease the side effects of taking anti-cancer drugs “dramatically” because the drug does not target non-cancerous cells. Current cancer drugs can destroy non-cancerous cells, thus creating sometimes severe side effects.
Morad said if scientists could come up with 100 different peptides, they believe various combinations could treat each kind of cancer.
Personalized cancer treatment:
MuTaTo is also a personalized drug. That means cancer patients can give a biopsy to the lab. The scientists will analyze it and give the patient a personalized cocktail of MuTaTo that will specifically destroy their particular cancer.
“Each patient will get his own MuTaTo that will fit perfectly his cancer. He would have almost no side effects and in no time be cured completely because the cancer cells would be completely killed – every one of them,” he said.
It really does sound like a miracle drug. They company has finished testing the drug in mice and plans to begin clinical drug trials soon.
Also the company CEO makes clear he doesn’t care about money, that he just wants to cure cancer patients.